Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).

[1]  J. Estève,et al.  An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies , 2007, Statistics in medicine.

[2]  J. Smith,et al.  Influence of sex on lung cancer histology, stage, and survival in a midwestern United States tumor registry. , 2005, Clinical lung cancer.

[3]  G. Vlastos,et al.  Modeling the effect of age in T1-2 breast cancer using the SEER database , 2005, BMC Cancer.

[4]  J. Faivre,et al.  Time trends in the treatment and survival of recurrences from colorectal cancer. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  N. Rioux-Leclercq,et al.  Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience , 2005 .

[6]  G. Hédelin,et al.  Non-small-cell lung cancer in a French department, (1982–1997): management and outcome , 2005, British Journal of Cancer.

[7]  Mike Quinn,et al.  Standard cancer patient population for age standardising survival ratios. , 2004, European journal of cancer.

[8]  Paul W Dickman,et al.  Regression models for relative survival , 2004, Statistics in medicine.

[9]  G. Hédelin,et al.  Survival of women with breast cancer in France: variation with age, stage and treatment , 2001, Breast Cancer Research and Treatment.

[10]  F. Berrino,et al.  Variations in survival for invasive cervical cancer among European women, 1978–89 , 1999, Cancer Causes & Control.

[11]  M. Coleman,et al.  Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.

[12]  F. Khuri,et al.  Sex differences in survival in non-small cell lung cancer patients 1974-1998. , 2004, Acta oncologica.

[13]  Jarrett Rosenberg,et al.  The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database , 2004, Breast Cancer Research and Treatment.

[14]  E Carrani,et al.  The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  M. Coleman,et al.  EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  G. Hédelin,et al.  Cancer incidence and mortality in France over the period 1978-2000. , 2003, Revue d'epidemiologie et de sante publique.

[17]  P. Arveux,et al.  Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). , 2002, European journal of cancer.

[18]  C. Faivre-Finn,et al.  Colon cancer in France: evidence for improvement in management and survival , 2002, Gut.

[19]  Hermann Brenner,et al.  Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. , 2002, International journal of epidemiology.

[20]  G. Launoy,et al.  Evidence of improving survival of patients with rectal cancer in France: a population based study , 1999, Gut.

[21]  T. Hakulinen,et al.  Mixture models for cancer survival analysis: application to population-based data with covariates. , 1999, Statistics in medicine.

[22]  J. Estève,et al.  Relative survival and the estimation of net survival: elements for further discussion. , 1990, Statistics in medicine.

[23]  T. Hakulinen,et al.  Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.